These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20633151)

  • 1. Measuring quality of life in stroke subjects receiving an implanted neural prosthesis for drop foot.
    Kottink AI; Ijzerman MJ; Groothuis-Oudshoorn CG; Hermens HJ
    Artif Organs; 2010 May; 34(5):366-76. PubMed ID: 20633151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of an implantable 2-channel peroneal nerve stimulator on walking speed and activity in poststroke hemiplegia.
    Kottink AI; Hermens HJ; Nene AV; Tenniglo MJ; van der Aa HE; Buschman HP; Ijzerman MJ
    Arch Phys Med Rehabil; 2007 Aug; 88(8):971-8. PubMed ID: 17678657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an implantable two-channel peroneal nerve stimulator versus conventional walking device on spatiotemporal parameters and kinematics of hemiparetic gait.
    Kottink AI; Tenniglo MJ; de Vries WH; Hermens HJ; Buurke JH
    J Rehabil Med; 2012 Jan; 44(1):51-7. PubMed ID: 22124679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.
    Boonen A; Patel V; Traina S; Chiou CF; Maetzel A; Tsuji W
    J Rheumatol; 2008 Apr; 35(4):662-7. PubMed ID: 18278836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
    J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of an implantable peroneal nerve stimulator in subjects with chronic stroke and footdrop: a randomized controlled trial.
    Kottink AI; Hermens HJ; Nene AV; Tenniglo MJ; Groothuis-Oudshoorn CG; IJzerman MJ
    Phys Ther; 2008 Apr; 88(4):437-48. PubMed ID: 18218825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards physiological ankle movements with the ActiGait implantable drop foot stimulator in chronic stroke.
    Ernst J; Grundey J; Hewitt M; von Lewinski F; Kaus J; Schmalz T; Rohde V; Liebetanz D
    Restor Neurol Neurosci; 2013; 31(5):557-69. PubMed ID: 23756541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial.
    Glasziou P; Alexander J; Beller E; Clarke P;
    Health Qual Life Outcomes; 2007 Apr; 5():21. PubMed ID: 17462100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of drop foot using an implantable peroneal underknee stimulator.
    Strojnik P; Acimovic R; Vavken E; Simic V; Stanic U
    Scand J Rehabil Med; 1987; 19(1):37-43. PubMed ID: 3495033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a foot-drop stimulator and ankle-foot orthosis on walking performance after stroke: a multicenter randomized controlled trial.
    Everaert DG; Stein RB; Abrams GM; Dromerick AW; Francisco GE; Hafner BJ; Huskey TN; Munin MC; Nolan KJ; Kufta CV
    Neurorehabil Neural Repair; 2013 Sep; 27(7):579-91. PubMed ID: 23558080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
    McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
    J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in functional ambulation as a therapeutic effect of peroneal nerve stimulation in hemiplegia: two case reports.
    Sheffler LR; Hennessey MT; Naples GG; Chae J
    Neurorehabil Neural Repair; 2007; 21(4):366-9. PubMed ID: 17369519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
    Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of ankle movements with the ActiGait implantable drop foot stimulator: a safe and reliable treatment option for permanent central leg palsy.
    Martin KD; Polanski WH; Schulz AK; Jöbges M; Hoff H; Schackert G; Pinzer T; Sobottka SB
    J Neurosurg; 2016 Jan; 124(1):70-6. PubMed ID: 26207599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common peroneal neuropathy in patients after first-time stroke.
    Tsur A
    Isr Med Assoc J; 2007 Dec; 9(12):866-9. PubMed ID: 18210927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially inappropriate drug use and health-related quality of life in the elderly.
    Franic DM; Jiang JZ
    Pharmacotherapy; 2006 Jun; 26(6):768-78. PubMed ID: 16716130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapeutic and orthotic effects of a foot drop stimulator on walking performance in progressive and nonprogressive neurological disorders.
    Stein RB; Everaert DG; Thompson AK; Chong SL; Whittaker M; Robertson J; Kuether G
    Neurorehabil Neural Repair; 2010 Feb; 24(2):152-67. PubMed ID: 19846759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
    Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
    Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timecourse of health-related quality of life as determined 3, 6 and 12 months after stroke. Relationship to neurological deficit, disability and depression.
    Suenkeler IH; Nowak M; Misselwitz B; Kugler C; Schreiber W; Oertel WH; Back T
    J Neurol; 2002 Sep; 249(9):1160-7. PubMed ID: 12242533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.